Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
LIOM logo — The ultimate health wearable. Live consciously.

LIOM

The ultimate health wearable. Live consciously.

Founded 2017 Switzerland Pfaffikon, Switzerland 49 employees Series A Total: $81.63M AI, Biotechnology

General Information

Company Name LIOM
Founded Year 2017
Location Switzerland Pfaffikon, Switzerland +2
Employees 49
Industries AI, Biotechnology
Funding Stage Series A
Social

Get notified when LIOM moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Growth Metrics Aug 06, 2026

LIOM validated its technology across over 6 years with 130+ subjects, ensuring inclusivity by testing through dark skin.

Event Participation Aug 04, 2026

LIOM's Adler Perotte is scheduled to give a presentation at the University of Rochester regarding non-invasive glucose monitoring.

Get alerts when LIOM shows new signals

AI Insight

Bounce Watch AI
2 weeks ago

LIOM is demonstrating strong momentum towards its 2027 pre-order and 2028 launch, marked by active team expansion and significant scientific validation. The company is enhancing its market visibility through expert presentations, while its core non-invasive biomarker technology has undergone extensive validation across 130+ subjects over six years, including diverse skin tones. These recent developments substantially de-risk the product and signal advanced readiness for commercialization.

Signal Types
Hiring Product Development Market Validation Market Visibility
Strategic Labels
Technology Validation Team Scaling Market Readiness
Next Move: Hiring
·
Impact: 8/10
·
Ideal For: HealthTech VCs — Series A, Deep Tech Investors

About LIOM

LIOM, a Swiss startup founded in 2017, is pioneering in the fields of AI and Biotechnology with its groundbreaking health wearable technology. Under the slogan "The ultimate health wearable. Live consciously.", the company addresses a fundamental issue in health tracking: the absence of biochemical insights.

The company's innovative solution goes beyond existing wearables by offering a continuous, needle-free analysis of biochemical markers, initially focusing on glucose levels. This wearable technology, derived from over 8+ years of research by a team of 50+ scientists, is both calibration-free and non-invasive. Notably, it has been validated with over 130+ subjects and is safeguarded by 23 patent families.

LIOM secured a significant $16.33M in a Series A round on 01 December 2025, with investments from Red Bull Amplifier, Melih Odemis, Alejo Costa Ribalta, and Marc Maurer. The company's vision is advancing towards a product launch in 2028, with pre-orders available in 2027, marking a pivotal step in personal health management. Investors and partners are encouraged to explore collaboration opportunities with this innovative venture.

Taxonomy: health wearable technology, biochemistry monitoring, glucose monitoring, non-invasive technology, calibration-free measurement, AI-driven analytics, real-time health data, wearable innovation, biomarker analysis, health conscious living, patent-protected technology, optical technology, miniaturized devices, continuous health monitoring, lifestyle optimization

Services & Products

development of non-invasive health wearables
real-time biochemical monitoring
glucose metabolism tracking
data-driven health insights
health optimization technologies

Target Customers

health-conscious individuals fitness enthusiasts individuals monitoring metabolic health people interested in preventive health care patients with glucose regulation concerns

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.33M 4
Red Bull Amplifier
Melih Odemis, Alejo Costa Ribalta +1 		01 Dec 2025
Series A $25.00M - 01 Dec 2024
Convertible Note $15.00M - 01 Jan 2024
Early VC $18.00M 8
The Group Ventures b2venture Ornament Health AG
Daniel Gutenberg, Young Sohn +3 		01 Apr 2021
Seed $7.30M - 01 Dec 2017

LIOM Alternatives & Competitors

LIOM vs
MYNERVA
MYNERVA

Revolutionizing the treatment of diabetic neuropathy with wearable technologies.

LIOM vs
Modo Bio
Modo Bio United States

Own Your Health

1 employees
Health Care, Health and Wellness
LIOM vs
Novioscan B.V.
Novioscan B.V. The Netherlands

SENS-U STAY DRY PLAY FREE

8 employees
Medical Devices
Compare LIOM vs Novioscan B.V.
Also compare with: LIOM vs Soulfit Soulfit LIOM vs paó paó

FAQ About LIOM

The ultimate health wearable. Live consciously.
LIOM was founded in 2017.
LIOM is headquartered in Pfaffikon, Switzerland.
LIOM operates in the following industries: AI, Biotechnology.
LIOM has approximately 49 employees.
LIOM has completed 5 funding rounds, raising a total of $81.63M. The latest funding stage is Series A.
LIOM offers: development of non-invasive health wearables, real-time biochemical monitoring, glucose metabolism tracking, data-driven health insights, health optimization technologies.
Top alternatives and competitors to LIOM include MYNERVA, Modo Bio, Novioscan B.V., Soulfit, paó. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LIOM and MYNERVA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LIOM and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy